Myocardial protection during resuscitation from cardiac arrest

Current Opinion in Critical Care

Volumn 9, Issue 3, 2003, Pages 199-204

  Gazmuri, Raúl J ^a,b,c   Ayoub, Iyad M ^b,c   Kolarova, Julieta ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Medical Service   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiac arrest; Defibrillation; Myocardial function; Sodium hydrogen exchange; Vasopressor agent; Ventricular fibrillation

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADRENALIN; CARIPORIDE; CORBADRINE; ESMOLOL; HYPERTENSIVE AGENT; OXYGEN RADICAL; POTASSIUM CHANNEL; SODIUM PROTON EXCHANGE PROTEIN; VASOPRESSIN;

AMINO ACID METABOLISM; DEFIBRILLATION; DRUG INDICATION; ELECTRIC SHOCK; HEART ARREST; HEART FUNCTION; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HUMAN; MYOCARDIAL DISEASE; NONHUMAN; PROTEIN FUNCTION; RECURRENT DISEASE; REPERFUSION INJURY; RESUSCITATION; REVIEW; SARCOLEMMA; SIDE EFFECT; SURVIVAL; TECHNIQUE; TREATMENT OUTCOME; VOLKMANN CONTRACTURE; WAVEFORM;

ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; CONTRACTURE; ELECTRIC COUNTERSHOCK; GUANIDINES; HEART; HEART ARREST; HUMANS; MYOCARDIAL ISCHEMIA; RECURRENCE; SARCOLEMMA; SODIUM-HYDROGEN ANTIPORTER; SULFONES; VASOCONSTRICTOR AGENTS; VENTRICULAR FIBRILLATION;

EID: 0038542814     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200306000-00005     Document Type: Review

References (61)

1. i elevation and ATP depletion. Am J Physiol 1990, 258:H9-H16.
2. Klouche K, Weil MH, Sun S, et al.: Evolution of the stone heart after prolonged cardiac arrest. Chest 2002, 122:1006-1011.
3. Ayoub IM, Kolarova JD, Yi Z, et al.: Sodium-hydrogen exchange inhibition during ventricular fibrillation: beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 2003, 107:1804-1809. Study in a swine model of ventricular fibrillation and closed-chest resuscitation demonstrating myocardial effects of NHE-1 inhibition during closed-chest resuscitation and the early postresuscitation interval.
4. Klouche K, Weil MH, Sun S, et al.: Stroke volumes generated by precordial compression during cardiac resuscitation. Crit Care Med 2002, 30:2626-2631.
5. Takino M, Okada Y: Firm myocardium in cardiopulmonary resuscitation. Resuscitation 1996, 33:101-106.
6. Klocke FJ, Ellis AK: Control of coronary blood flow. Annu Rev Med 1980, 31:489-508.
7. Gazmuri RJ, Ayoub IM, Hoffner E, et al.: Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide. Circulation 2001, 104:234-239.
8. Valenzuela TD, Roe DJ, Nichol G, et al.: Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl J Med 2000, 343:1206-1209. Important and now classic clinical study demonstrating the remarkable efficacy of the automatic external defibrillator when deployed with minimal delay after sudden cardiac death caused by ventricular fibrillation.
9. Niemann JT, Burian D, Garner D, et al.: Monophasic versus biphasic transthoracic countershock after prolonged ventricular fibrillation in a swine model. J Am Coll Cardiol 2000, 36:932-938.
10. Niemann JT, Cairns CB, Sharma J, et al.: Treatment of prolonged ventricular fibrillation. Immediate countershock versus high-dose epinephrine and CPR preceding countershock. Circulation 1992, 85:281-287. Animal study suggesting that under conditions of prolonged untreated ventricular fibrillation, a period of chest compression and epinephrine (intended to provide myocardial perfusion) could enhance the subsequent efficacy of electrical defibrillation.
11. Cobb LA, Fahrenbruch CE, Walsh TR, et al.: Influence of cardiopulmonary resuscitation prior to defibrillation in patients with out-of-hospital ventricular fibrillation. JAMA 1999, 281:1182-1188. Important clinical study suggesting that a 90-second interval of chest compression before attempting electrical defibrillation could improve outcome under conditions of prolonged untreated ventricular fibrillation.
12. Berg RA, Hilwig RW, Kern KB, et al.: Precountershock cardiopulmonary resuscitation improves ventricular fibrillation median frequency and myocardial readiness for successful defibrillation from prolonged ventricular fibrillation: a randomized, controlled swine study. Ann Emerg Med 2002, 40:563-570.
13. Kolarova JD, Ayoub IM, Yi Z, et al.: Optimal timing for electrical defibrillation after prolonged untreated ventricular fibrillation. Crit Care Med 2003, in press.
14. Ouyang P, Brinker JA, Bulkley BH, et al.: Ischemic ventricular fibrillation: the importance of being spontaneous. Am J Cardiol 1981, 48:455-459.
15. Qin H, Walcott GP, Killingsworth CR, et al.: Impact of myocardial ischemia and reperfusion on ventricular defibrillation patterns, energy requirements, and detection of recovery. Circulation 2002, 105:2537-2542. Animal study suggesting that very early refibrillation, rather than refractoriness to electrical shocks, may explain failure to defibrillate during ventricutar fibrillation associated with myocardial ischemia.
16. Mehta J, Runge W, Cohn JN, et al.: Myocardial damage after repetitive direct current shock in the dog: correlation between left ventricular end-diastolic pressure and extent of myocardial necrosis. J Lab Clin Med 1978, 91:272-289.
17. Gazmuri RJ, Deshmukh S, Shah PR: Myocardial effects of repeated electrical defibrillations in the isolated fibrillating rat heart. Crit Care Med 2000, 28:2690-2696.
18. White RD, Russell JK: Refibrillation, resuscitation and survival in out-of-hospital sudden cardiac arrest victims treated with biphasic automated external defibrillators. Resuscitation 2002, 55:17-23.
19. Franz MR: Monophasic action potentials recorded by contact electrode method. Genesis, measurement, and interpretations. In Monophasic Action Potentials: Bridging Cell and Bedside. Edited by Franz MR. Armonk, NY: Futura Publishing Co.; 2000:19-45.
20. Wirth KJ, Uhde J, Rosenstein B, et al.: K(ATP) channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs. Naunyn Schmiedebergs Arch Pharmacol 2000, 361:155-160.
21. Wirth KJ, Maier T, Busch AE: NHE1-inhibitor cariporide prevents the transient reperfusion-induced shortening of the monophasic action potential after coronary ischemia in pigs. Basic Res Cardiol 2001, 96:192-197. Initial study demonstrating that shortening of the action potential duration during ischemia and reperfusion in a swine model of regional coronary occlusion could be markedly attenuated by NHE-1 inhibition using cariporide.
22. Gazmuri RJ, Weil MH, Bisera J, et al.: Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 1996, 24:992-1000. Initial animal study describing the phenomenon of postresuscitation myocardial dysfunction in models of ventricular fibrillation and closed-chest resuscitation.
23. Kern KB, Hilwig RW, Rhee KH, et al.: Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 1996, 28:232-240. See [22•].
24. Kern KB: Postresuscitation myocardial dysfunction. Cardiol Clin 2002, 20:89-101.
25. Mullner M, Domanovits H, Sterz F, et al.: Measurement of myocardial contractility following successful resuscitation: quantitated left ventricular systolic function utilising non-invasive wall stress analysis. Resuscitation 1998, 39:51-59.
26. Deantonio HJ, Kaul S, Lerman BB: Reversible myocardial depression in survivors of cardiac arrest. Pacing Clin Electrophysiol 1990, 13:982-985.
27. Gazmuri RJ, Weil MH, von Planta M, et al.: Cardiac resuscitation by extracorporeal circulation after failure of conventional CPR. J Lab Clin Med 1991, 118:65-73.
28. Kern KB, Hilwig RW, Berg RA, et al.: Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation 1997, 95:2610-2613.
29. Ciuffo AA, Ouyang P, Becker LC, et al.: Reduction of sympathetic inotropic response after ischemia in dogs. Contributor to stunned myocardium. J Clin Invest 1985, 75:1504-1509.
30. Becker LC, Levine JH, DiPaula AF, et al.: Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol 1986, 7:580-589.
31. Clark CB, Zhang Y, Davies LR, et al.: Transthoracic biphasic waveform defibrillation at very high and very low energies: a comparison with monophasic waveforms in an animal model of ventricular fibrillation. Resuscitation 2002, 54:183-186.
32. Tang W, Weil MH, Sun S, et al.: The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. J Am Coll Cardiol 1999, 34:815-822. Study demonstrating reduced postresuscitation myocardial dysfunction associated with the use of biphasic waveform defibrillation in a swine model of ventricular fibrillation and closed-chest resuscitation.
33. Tang W, Weil MH, Sun S, et al.: A comparison of biphasic and monophasic waveform defibrillation after prolonged ventricular fibrillation. Chest 2001, 120:948-954. See [32•].
34. Leng CT, Paradis NA, Calkins H, et al.: Resuscitation after prolonged ventricular fibrillation with use of monophasic and biphasic waveform pulses for external defibrillation. Circulation 2000, 101:2968-2974.
35. Schneider T, Martens PR, Paschen H, et al.: Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Optimized Response to Cardiac Arrest (ORCA) Investigators. Circulation 2000, 102:1780-1787. Clinical study demonstrating increased success of initial defibrillation and return of spontaneous circulation with the use of impedance-compensating biphasic truncated waveform defibrillation. The study was not powered to assess effects on long-term survival.
36. Ehsani A, Ewy GA, Sobel BE: Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity. Am J Cardiol 1976, 37:12-18.
37. Doherty PW, McLaughlin PR, Billingham M, et al.: Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol 1979, 43:225-232.
38. Runsio M, Bergfeldt L, Brodin LA, et al.: Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography. Eur Heart J 1997, 18:124-131.
39. Brown CG, Dzwonczyk R, Martin DR: Physiologic measurement of the ventricular fibrillation EGG signal: estimating the duration of ventricular fibrillation. Ann Emerg Med 1993, 22:70-74.
40. Noc M, Weil MH, Gazmuri RJ, et al.: Ventricular fibrillation voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J Lab Clin Med 1994, 124:421-426.
41. Brown CG, Griffith RF, Van Ligten P, et al.: Median frequency-a new parameter for predicting defibrillation success rate. Ann Emerg Med 1991, 20:787-789.
42. Strohmenger HU, Lindner KH, Brown CG: Analysis of the ventricular fibrillation ECG signal amplitude and frequency parameters as predictors of countershock success in humans. Chest 1997, 111:584-589.
43. Povoas HP, Weil MH, Tang W, et al.: Predicting the success of defibrillation by electrocardiographic analysis. Resuscitation 2002, 53:77-82.
44. Ditchey RV, Lindenfeld J: Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation 1988, 78:382-389.
45. Tang W, Weil MH, Sun S, et al.: Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995, 92:3089-3093.
46. Ditchey RV, Rubio-Perez A, Slinker BK: Beta-adrenergic blockade reduces myocardial injury during experimental cardiopulmonary resuscitation. J Am Coll Cardiol 1994, 24:804-812.
47. Wenzel V, Lindner KH: Arginine vasopressin during cardiopulmonary resuscitation:laboratory evidence, clinical experience and recommendations, and a view to the future. Crit Care Med 2002, 30(suppl):S157-S161.
48. 2-adrenoceptor agonist as a vasopressor agent for resuscitation from ventricuiar fibrillation during chest compression.
49. Klouche K, Weil MH, Tang W, et al.: A selective alpha(2)-adrenergic agonist for cardiac resuscitation. J Lab Clin Med 2002, 140:27-34. See [48••].
50. Cai JJ, Morgan DA, Haynes WG, et al.: Alpha 2-Adrenergic stimulation is protective against ischemia-reperfusion-induced ventricular arrhythmias in vivo. Am J Physiol 2002, 283:H2606-H2611.
51. + exchange. Am J Physiol 1988, 255:H608-H615. Landmark study in which increased sarcolemmal sodium-hydrogen exchange was proposed as a possible mechanism of ischemia and reperfusion injury.
52. Lazdunski M, Frelin C, Vigne P: The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol 1985, 17:1029-1042.
53. Avkiran M: Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol 1999, 83:10G-17G.
54. Imahashi K, Kusuoka H, Hashimoto K, et al.: Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res 1999, 84:1401-1406. Interesting study demonstrating an association between the magnitude of intracellular sodium accumulation during ischemia and the subsequent severity of post-ischemic myocardial dysfunction.
55. Mosca SM, Cingolani HE: Comparison of the protective effects of ischemic preconditioning and the Na+/H+ exchanger blockade. Naunyn Schmiedebergs Arch Pharmacol 2000, 362:7-13.
56. Mosca SM, Cingolani HE: The Na+/Ca2+ exchanger as responsible for myocardial stunning [in Spanish]. Medicina (B Aires) 2001, 61:167-173.
57. Ditchey RV, Horwitz LD: Metabolic evidence of inadequate coronary blood flow during closed-chest resuscitation in dogs. Cardiovasc Res 1985, 19:419-425.
58. Gazmuri RJ, Hoffner E, Kalcheim J, et al.: Myocardial protection during ventricular fibrillation by reduction of proton-driven sarcolemmal sodium influx. J Lab Clin Med 2001, 137:43-55.
59. von Planta M, von Planta I, Wagner O, et al.: Adenosine during cardiac arrest and cardiopulmonary resuscitation: a placebo-controlled, randomized trial. Crit Care Med 1992, 20:645-649. Interesting study demonstrating in a rat model of ventricular fibrillation and closed-chest resuscitation successful resuscitation in the presence of adenosine despite profound decreases in coronary perfusion pressure.
60. Tang W, Weil MH, Sun S, et al.: K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction. Am J Physiol 2000, 279:H1609-H1615.
61. Seaberg DC, Menegazzi JJ, Check B, et al. Use of a cardiocerebral-protective drug cocktail prior to countershock in a porcine model of prolonged ventricular fibrillation. Resuscitation 2001, 51:301-308.